Insulet (PODD) Misses Q4 EPS by 4c, Revs Beat
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $141.55 -4.02%
Revenue Growth %: +18.1%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.15 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Citi turns more bullish on trucking stocks
- ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
